Loci of TCF7L2, HHEX and IDE on chromosome 10q and the susceptibility of their genetic polymorphisms to type 2 diabetes

Experimental and Clinical Endocrinology and Diabetes

Volumn 117, Issue 4, 2009, Pages 186-190

  Nordman, S ^a   Ostenson C G ^a   Efendic, S ^a   Gu, H F ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

HHEX; IDE; TCF7L2; Type 2 diabetes

Indexed keywords

GLUCOSE; HHEX PROTEIN; HOMEODOMAIN PROTEIN; INSULINASE; TRANSCRIPTION FACTOR 7 LIKE 2; UNCLASSIFIED DRUG; DNA; HHEX PROTEIN, HUMAN; T CELL FACTOR 4; T CELL FACTOR PROTEIN; TRANSCRIPTION FACTOR;

ADULT; ARTICLE; CHROMOSOME 10Q; CONTROLLED STUDY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENOTYPE PHENOTYPE CORRELATION; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; SINGLE NUCLEOTIDE POLYMORPHISM; BLOOD; CHROMOSOME 10; CHROMOSOME MAP; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; ISOLATION AND PURIFICATION; PHENOTYPE;

CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 10; DIABETES MELLITUS, TYPE 2; DNA; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HOMEODOMAIN PROTEINS; HUMANS; INSULYSIN; PHENOTYPE; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT LOCI; TCF TRANSCRIPTION FACTORS; TRANSCRIPTION FACTORS;

EID: 67651209216     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0028-1100419     Document Type: Article

References (32)

1. Reynisdottir I, Thorleifsson G, Benediktsson R et al. Localization of a susceptibility gene for type 2 diabetes to chromosome 5q34-q35.2. Am J Hum Genet 2003; 73: 323-335
2. Wiltshire S, Hattersley AT, Hitman GA et al. A genomewide scan for loci predisposing to type 2 diabetes in a U.K. population (the Diabetes UK Warren 2 Repository): analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q. Am J Hum Genet 2001; 69: 553-569
3. Watanabe RM, Ghosh S, Langefeld CD et al. The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. I. An autosomal genome scan for genes that predispose to type 2 diabetes. Am J Hum Genet 2000; 67: 1174-1185
4. Duggirala R, Blangero J, Almasy L et al. Linkage of type 2 diabetes mellitus and of age at onset to a genetic location on chromosome 10q in Mexican Americans. Am J Hum Genet 1999; 64: 1127-1140
5. Ehm MG, Karnoub MC, Sakul H et al., American Diabetes Association GENNID Study Group. Genetics of NIDDM. Genomewide search for type 2 diabetes susceptibility genes in four American populations. Am J Hum Genet 2000; 66: 1871-1881
6. Duckworth WC, Bennett RG, Hamel FG. Insulin degradation: progress and potential. Endocr Rev 1998; 19: 608-624
7. Fakhrai-Rad H, Nikoshkov A, Kamel A et al. Insulin-degrading enzyme identified as a candidate diabetes susceptibility gene in GK rats. Hum Mol Genet 2000; 9: 2149-2158
8. Karamohamed S, Demissie S, Volcjak J et al., NHLBI Framingham Heart Study. Polymorphisms in the insulin-degrading enzyme gene are associated with type 2 diabetes in men from the NHLBI Framingham Heart Study. Diabetes 2003; 52: 1562-1567
9. Gu HF, Efendic S, Nordman S et al. Quantitative trait loci near the insulin-degrading enzyme (IDE) gene contribute to variation in plasma insulin levels. Diabetes 2004; 53: 2137-2142
10. Furukawa Y, Shimada T, Furuta H et al. Polymorphisms in the IDEKIF11-HHEX gene locus are reproducibly associated with type 2 diabetes in a Japanese population. J Clin Endocrinol Metab 2008; 93: 310-314
11. Schulze MB, Al-Hasani H, Boeing H et al. Variation in the HHEX-IDE gene region predisposes to type 2 diabetes in the prospective, population-based EPIC-Potsdam cohort. Diabetologia 2007; 50: 2405-2407
12. Sladek R, Rocheleau G, Rung J et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007; 445: 881-885
13. Horikoshi M, Hara K, Ito C et al. Variations in the HHEX gene are associated with increased risk of type 2 diabetes in the Japanese population . Diabetologia 2007; 50: 2461-2466
14. Zeggini E, Weedon MN, Lindgren CM et al., Wellcome Trust Case Control Consortium (WTCCC). Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 2007; 316: 1336-1341
15. Scott LJ, Mohlke KL, Bonnycastle LL et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007; 316: 1341-1345
16. Grant SF, Thorleifsson G, Reynisdottir I et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 2006; 38: 320-323
17. Buchbinder S, Rudofsky G Jr, Humpert PM et al. The DG10S478 variant in the TCF7L2 gene is not associated with microvascular complications in type 2 diabetes. Exp Clin Endocrinol Diabetes 2008; 116: 211-214
18. Weedon MN. The importance of TCF7L2. Diabet Med 2007; 24: 1062-1066
19. Elbein SC. Evaluation of polymorphisms known to contribute to risk for diabetes in Aferican and African-American populations. Curr Opin Clin Nutr Metab Care 2007; 10: 415-419
20. Florez JC. The new type 2 diabetes gene TCF7L2. Curr Opin Clin Nutr Metab Care 2007; 10: 391-396 (Pubitemid 46934105)
21. Frayling TM. A new era in finding type 2 diabetes gene-the unusual suspects. Diabet Med 2007; 24: 696-701
22. Owen KR, MacCarthy MI. Genetics of type 2 diabetes. Curr Opin Clin Nutr Metab Care 2007; 17: 239-244
23. Lyssenko V, Lupi R, Marchetti P et al. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest 2007; 117: 2155-2163
24. Carlsson S, Persson PG, Alvarsson M et al. Weight history, glucose intolerance, and insulin levels in middle-aged Swedish men. Am J Epidemiol 1998; 148: 539-545
25. Wang J, Kuusisto J, Vänttinen M et al. Variants of transcription factor 7-like 2 (TCF7L2) gene predict conversion to type 2 diabetes in the Finnish Diabetes Prevention Study and are associated with impaired glucose regulation and impaired insulin secretion. Diabetologia 2007; 50: 1192-1200
26. Elbein SC, Chu WS, Das SK et al. Transcription factor 7-like 2 polymorphisms and type 2 diabetes, glucose homeostasis traits and gene expression in US participants of European and African descent. Diabetologia 2007; 50: 1621-1630
27. Nordman S. Identification of susceptibility genes in type 2 diabetes. ISBN 978-91-7375-492-1 200; 1-46
28. Weedon MN, MacCarthy MI, Hitman G et al. Combining information from common type 2 diabetes risk polymorphisms improves disease prediction. PLoS Med 2006; 3: 1877-1882
29. Cauchi S, Meyre D, Dina C et al. Transcription factor TCF7L2 genetic study in the French population: expression in human beta-cells and adipose tissue and strong association with type 2 diabetes. Diabetes 2006; 55: 2903-2908
30. Humphries SE, Gable D, Cooper JA et al. Common variants in the TCF7L2 gene and predisposition to type 2 diabetes in UK European Whites, Indian Asians and Afro-Caribbean men and women. J Mol Med 2006; 84: 1005-1014
31. Schäfer SA, Tschritter O, Machicao F et al. Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms. Diabetologia 2007; 50: 2443-2450
32. Liu Z, Habener JF. Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic beta cell proliferation. J Bio Chem 2008; 283: 8723-8735